...
首页> 外文期刊>Breast cancer research and treatment. >The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.
【24h】

The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.

机译:穴位刺激治疗乳腺癌患者治疗相关不良事件的疗效:系统评价。

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present study was to scrutinize the evidence on the use of acupoint stimulation for managing therapy-related adverse events in breast cancer. A comprehensive search was conducted on eight English and Chinese databases to identify clinical trials designed to examine the efficacy of acupressure, acupuncture, or acupoint stimulation (APS) for the management of adverse events due to treatments of breast cancer. Methodological quality of the trials was assessed using a modified Jadad scale. Using pre-determined keywords, 843 possibly relevant titles were identified. Eventually 26 papers, 18 in English and eight in Chinese, satisfied the inclusion criteria and entered the quality assessment stage. The 26 articles were published between 1999 and 2008. They assessed the application of acupoint stimulation on six disparate conditions related to anticancer therapies including vasomotor syndrome, chemotherapy-induced nausea and vomiting, lymphedema, post-operation pain, aromatase inhibitors-related joint pain and leukopenia. Modalities of acupoint stimulation used included traditional acupuncture, acupressure, electroacupuncture, and the use of magnetic device on acupuncture points. Overall, 23 trials (88%) reported positive outcomes on at least one of the conditions examined. However, only nine trials (35%) were of high quality; they had a modified Jadad score of 3 or above. Three high quality trials revealed that acupoint stimulation on P6 (NeiGuang) was beneficial to chemotherapy-induced nausea and vomiting. For other adverse events, the quality of many of the trials identified was poor; no conclusive remarks can be made. Very few minor adverse events were observed, and only in five trials. APS, in particular acupressure on the P6 acupoint, appears beneficial in the management of chemotherapy-induced nausea and vomiting, especially in the acute phase. More well-designed trials using rigorous methodology are required to evaluate the effectiveness of acupoint stimulation interventions on managing other distress symptoms.
机译:本研究的目的是仔细研究使用穴位刺激治疗乳腺癌中与治疗相关的不良事件的证据。在八个英文和中文数据库中进行了全面搜索,以鉴定旨在检查穴位按摩,针刺或穴位刺激(APS)在治疗乳腺癌所致不良事件方面的功效的临床试验。使用改良的Jadad量表评估试验的方法学质量。使用预定的关键字,确定了843个可能相关的标题。最终有26篇论文(英语18篇,中文8篇)满足纳入标准,进入质量评估阶段。 26篇文章发表于1999年至2008年之间。他们评估了穴位刺激在与抗癌疗法相关的6种不同条件下的应用,这些条件包括血管舒缩综合征,化疗引起的恶心和呕吐,淋巴水肿,术后疼痛,芳香化酶抑制剂相关的关节痛和白细胞减少症。所采用的穴位刺激方式包括传统的针灸,穴位按摩,电针灸以及在穴位上使用磁性装置。总体而言,有23项试验(占88%)在至少一种检查条件下报告为阳性。但是,只有九项试验(35%)是高质量的。他们的修改后的Jadad得分为3或更高。三项高质量试验表明,穴位刺激P6(内光)对化疗引起的恶心和呕吐有益。对于其他不良事件,许多已鉴定的试验质量较差;没有结论性的言论。仅在五项试验中观察到很少的轻微不良事件。 APS,特别是对P6穴位的指压,在处理化学疗法引起的恶心和呕吐方面,尤其是在急性期,似乎是有益的。需要使用严格的方法进行更精心设计的试验,以评估穴位刺激干预措施在处理其他窘迫症状方面的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号